SHAUNDRA PARSLEY: Open Payments
NPI 1427688662 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 13 payments from 6 companies in 2025. Trend: 2023 $378 · 2024 $803 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $261 |
| Supernus Pharmaceuticals, Inc. | 4 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $143 |
| Indivior Inc. | 1 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| TMS NeuroHealth Centers Inc. | 1 | $14 |
Products named: Auvelity, Qelbree, CAPLYTA, SUBLOCADE, INGREZZA, TMS NeuroHealth Centers Inc..
Industry payments across MD — which companies pay providers there.
